Biomet reveals weak 2nd quarter but outlook still optimistic, says analyst
This article was originally published in Clinica
Executive Summary
Despite reporting a shortfall in its second quarter earnings for fiscal 2006, Biomet's strong growth in its hip and knee implant sales will ultimately create shareholder value.